19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Kids of Opioid-Using Parents May Be More Likely to Attempt SuicideCholesterol Levels Improving Among U.S. KidsEarlier Bedtimes Help Kids Fight Obesity1 in 5 Kids Don't Strap on Helmets Before BikingParents, Here's How to Protect Your Child During Measles OutbreaksMore Than 600,000 Opioid Abusers Raising Kids in U.S.2 of 3 Parents Read Texts While DrivingFear of Dentist May Start Early for Minority Kids -- With Good ReasonMilitary Tourniquets Might Save Kids' Lives During School ShootingsE-Cigarettes Used in 5% of U.S. Homes With KidsMany Kids With Chronic Illness Are Still Happy: StudyDiet Sodas May Not Help Kids Cut CaloriesAsthma Inhalers Incorrectly Used by Most Kids in StudyNewer Diabetes Drug Shows Promise in Kids, TeensBenlysta Approved for Children With LupusParents, Protect Your Kids as Measles Outbreaks SpreadHow Much Does Your Kid Weigh? Chances Are, You're UnderestimatingFor Kids, Obesity and Mental Health Woes Often Go Hand-in-HandWhy Kids Should Play More Than One SportBetter Food Assistance Programs Might Lower Childhood Obesity RatesMany U.S. Kids Don't Drink Enough Water, and Obesity May Be the ResultStrict Blood Pressure Limits for Kids Tied to Heart Health LaterAlmost Half of Young Asthma Patients Misuse InhalersCan Games and Apps Help Your Kids Learn?Kids Can Get UTIs, TooInactive Lifestyle Begins as Early as Age 7: StudyWhy the HPV Vaccine Is More Important Than EverMore Time Spent in Sports, Faster Healing From ConcussionHow to Cut Your Kids' Sugar IntakeLiving Near Major Roads Can Slow Kids' Development: StudySuicidal Behavior Nearly Doubles Among U.S. KidsTeaching Kids the Importance of an ApologyAHA News: Kids With High Blood Pressure Need Smooth Transition to Adult CarePot During Pregnancy May Raise Child's Psychosis RiskMost Parents Want Age Limits on Football TacklingKids Who Specialize in One Sport Too Early Are Likely to Get Hurt: StudyHealth Tip: Responsibilities of Non-VaccinationThe 1-Parent Family and Kids' Health RisksPesticides Tied to Autism Risk in KidsStrengthening Family Ties Through Online GamingReworked Nasal Flu Vaccine Looks Good for Kids, Pediatricians' Group SaysMore U.S. Teens, Kids Seeking Mental Health Care in ERsAHA News: Overweight Kids at Higher Risk for Blood Clots as AdultsHow to Protect Your Kids From DrowningFewer Boys Are Suffering Head Injuries, But Rate Rises for GirlsWhen Can Kids Return to Play After a Concussion?One-Third of U.S. Kids Have Back Pain, Study SaysMany Parents Think Vaping Around Kids Is FineTime Change Tougher for Kids With Mental Health IssuesLargest Study Ever Finds No Link Between Measles Vaccine, Autism
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting

Newer Diabetes Drug Shows Promise in Kids, Teens

HealthDay News
by -- Robert Preidt
Updated: Apr 30th 2019

new article illustration

TUESDAY, April 30, 2019 (HealthDay News) -- A type 2 diabetes drug for adults also controls blood sugar levels in children and teens with the disease, researchers report.

Type 2 diabetes is on the rise among children and teens, but they have fewer treatment choices than adults, the study authors said. Currently, the only drugs approved for treatment of children and teens with type 2 diabetes are metformin and insulin.

This study, led by researchers at Yale University, looked at how the drug liraglutide (Victoza) affected blood sugar and glycated hemoglobin (or A1c) levels in patients aged 10 to 16 with type 2 diabetes who were already taking metformin with or without insulin.

Half of the patients took metformin plus liraglutide, and the other half took metformin plus an inactive placebo. The participants' blood sugar and A1c levels were checked after six months and one year.

For those with type 2 diabetes, an A1c level below 7% means their diabetes is relatively well-controlled, the study authors noted.

After six months, those in the liraglutide group had substantially lower blood sugar levels and their A1c levels were 1.1 percentage points lower than those in the placebo group, the findings showed.

After one year, the liraglutide group had A1c levels 1.3 percentage points lower than the placebo group, which had an average 0.5 percentage point increase.

The investigators also found that, after one year, nearly two-thirds of the liraglutide group had A1c levels under the 7% target, compared to one-third of the placebo group.

The study, published online April 28 in the New England Journal of Medicine, was funded by the drug's maker, Novo Nordisk.

The findings could be "transformational" for children and teens with type 2 diabetes, according to study first author Dr. William Tamborlane, a pediatric endocrinologist at Yale.

Metformin is the most popular initial treatment for type 2 diabetes in children and teens, but it often leads to an early loss of blood sugar control, and add-on treatment with insulin usually fails to lower blood sugar levels, the researchers explained in a university news release.

"As a result of this study, we anticipate that youth with type 2 diabetes will soon have a third option that has not previously been available," Tamborlane said.

More information

The U.S. Centers for Disease Control and Prevention explains how to prevent type 2 diabetes in children.